TWIN PEAKS WEALTH ADVISORS, LLC

Position in AZN — Astrazeneca PLC

CIK 2006218 BURLINGAME, CA

Position in AZN

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$232,853

+$56,144 QoQ

Shares Held

1,228

+37.1% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.16%

of 13F equity value

Holder Rank

#1,142

of 1,459 holders

Holding Since

Dec 2025

3 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

TWIN PEAKS WEALTH ADVISORS, LLC holds $3,898,189 across 6 Drug Manufacturers - General names. AZN ranks #5 (6.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	1,331	$1,596,441
2	ABBV	AbbVie Inc.	3,187	$801,976
3	JNJ	Johnson & Johnson	2,930	$744,132
4	MRK	Merck & Co., Inc.	2,328	$299,148
5	AZN	Astrazeneca PLC This page	1,228	$232,853
6	NVS	Novartis AG	1,427	$223,639

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$232,853	1,228	+37.1%	Shares	Sole	2026-08-13
2026-03-31	$176,709	896	-19.1%	Shares	Sole	2026-05-08
2025-12-31	$101,858	1,108	—	Shares	Sole	2026-02-10
No filing history on record for this holder in this stock.